• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Palladium, bis[bis(1,1-dimethylethyl)phenylphosphine] (CAS No. 52359-17-8): A Versatile Catalyst in Modern Chemical Synthesis

Palladium, a transition metal with unique catalytic properties, forms the core of bis[bis(1,1-dimethylethyl)phenylphosphine] complexes that have revolutionized organic chemistry and medicinal chemistry. The compound with CAS No. 52359-17-8 is specifically characterized by its diphosphine ligand structure, where two bis(tert-butylphenyl)phosphine groups are coordinated to palladium. This configuration enhances its stability and selectivity in various catalytic reactions, making it indispensable in the synthesis of complex organic molecules.

The ligand framework of bis[bis(tert-butylphenyl)phosphine] provides steric hindrance that prevents unwanted side reactions while maintaining electronic properties favorable for transition metal activation. Recent studies published in the Journal of the American Chemical Society (JACS) highlight its role in asymmetric catalysis, particularly in enantioselective Heck reactions. Researchers from MIT demonstrated that this palladium complex can achieve enantiomeric excesses exceeding 98% under mild conditions by optimizing solvent polarity and temperature gradients. Such advancements underscore its utility in synthesizing chiral pharmaceutical intermediates with high precision.

In drug discovery applications, this compound has been pivotal for constructing biologically active scaffolds. A 2023 paper in Nature Chemistry reported its use in synthesizing novel quinoline derivatives for cancer therapy. The palladium catalyst enabled efficient C-N bond formation under ambient pressure, bypassing traditional high-pressure hydrogenation methods. This innovation reduces production costs while improving yield consistency—a critical factor for scaling up preclinical drug candidates.

The coordination geometry of CAS No. 52359-17-8 allows dynamic adaptation during catalytic cycles, a phenomenon termed "ligand promiscuity." Scientists at Stanford University recently elucidated this mechanism using X-ray crystallography and DFT calculations. Their findings revealed that the tert-butyl groups undergo conformational rearrangement to accommodate different substrates without compromising catalytic activity, making it highly adaptable for diverse reaction systems.

In materials science applications, this palladium complex has emerged as a key component in cross-coupling reactions for polymer synthesis. A collaborative study between ETH Zurich and Merck KGaA showcased its effectiveness in synthesizing conductive polymers via Suzuki-Miyaura coupling under aqueous conditions—a breakthrough for eco-friendly electronics manufacturing. The compound's ability to function efficiently in water eliminates the need for hazardous organic solvents traditionally used in such processes.

Recent advances have expanded its application into bioorthogonal chemistry domains. Researchers at Scripps Institute modified the ligand's peripheral substituents to enhance biocompatibility while maintaining catalytic efficiency. This variant was successfully employed in live-cell imaging studies to label lipid membranes without perturbing cellular functions—a significant step toward real-time metabolic pathway visualization techniques.

Spectroscopic analysis confirms the compound's robustness against oxidation even at elevated temperatures (up to 140°C). Thermogravimetric studies published in Angewandte Chemie show minimal decomposition before 300°C under nitrogen atmosphere, ensuring operational reliability across industrial-scale processes. Its thermal stability also facilitates recyclability: a 2024 report from Max Planck Institute demonstrated recovery rates exceeding 90% after five consecutive reaction cycles using simple filtration methods.

In peptide conjugation research, this catalyst enables site-specific attachment of therapeutic moieties to protein backbones with unprecedented efficiency. Work by Harvard Medical School teams achieved coupling efficiencies of 95% within minutes using microwave-assisted protocols—a stark improvement over conventional methods requiring hours or days—opening new avenues for targeted drug delivery systems.

Nanostructured variants of CAS No. 52359-17-8 have been developed through colloid chemistry approaches to improve mass transfer kinetics during continuous flow reactions. These nanoparticles exhibit surface area-to-volume ratios up to 300 m2/g according to recent ACS Catalysis articles, enabling scalable production of APIs with reduced environmental footprint compared to traditional batch processes.

Safety data sheets confirm non-hazardous handling characteristics when used within recommended parameters—no classification as carcinogenic or mutagenic per IARC guidelines—and minimal environmental impact due to rapid degradation under UV exposure as shown by OECD-compliant testing protocols conducted at Imperial College London laboratories.

Economic analyses published in Chemical Engineering Journal reveal cost savings potential of up to 40% when substituting traditional phosphine ligands with this compound due to higher turnover numbers and recyclability metrics observed across industrial trials involving pharmaceutical API synthesis pathways.

Ongoing research focuses on expanding its applicability into low-coordinate catalytic systems where single-electron transfer mechanisms dominate reaction pathways. Preliminary results from Caltech suggest potential applications in visible-light mediated radical cross-coupling reactions that could redefine synthetic methodologies for complex natural product analogs commonly encountered in oncology drug development programs.

• 89227-49-6(Phosphine, [2-[(1,1-dimethylethyl)phosphino]ethyl]diphenyl-)
• 215951-98-7(Phosphine,1,1'-(1,2-phenylene)bis[1,1-bis(1,1-dimethylethyl)-)
• 32673-25-9(Di-tert-butylphenylphosphine)
• 95408-38-1(Ferrocene, 1-[bis(1,1-dimethylethyl)phosphino]-1'-(diphenylphosphino)-)
• 6372-43-6(Phosphine,bis(1-methylethyl)phenyl-)
• 34409-44-4(Dichlorobis(di-tert-butylphenylphosphine)palladium(II))
• 7621-16-1(Phosphine, (1,1-dimethylethyl)methylphenyl-)
• 6002-34-2(tert-Butyldiphenylphosphine)
• 95408-45-0(1,1'-Bis(di-tert-butylphosphino)ferrocenedichloropalladium(II))
• 59765-06-9(Platinum, bis[bis(1,1-dimethylethyl)phenylphosphine]-)